We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

32 hedge funds and large institutions have $1.02M invested in Bionano Genomics in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

0% more funds holding

Funds holding: 32 → 32 (0)

0.85% less ownership

Funds ownership: 8.7% → 7.85% (-0.85%)

25% less capital invested

Capital invested by funds: $1.35M → $1.02M (-$336K)

Holders
32
Holders Change
–
Holders Change %
0%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$129K
2
Prudential Financial
Prudential Financial
New Jersey
+$35.9K
3
CAM
Carret Asset Management
New York
+$33.2K
4
TSS
Two Sigma Securities
New York
+$23.1K
5
GCP
GSA Capital Partners
United Kingdom
+$20K

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$258K
2
Two Sigma Investments
Two Sigma Investments
New York
-$62K
3
Jane Street
Jane Street
New York
-$33.9K
4
RS
R Squared
Hong Kong
-$21.1K
5
Bank of America
Bank of America
North Carolina
-$12.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
1
GSA Capital Partners
United Kingdom
$413K +$20K +15,586 +5%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$196K +$129K +100,767 +151%
CAM
3
Carret Asset Management
New York
$81.9K +$33.2K +25,900 +59%
VCM
4
Vanguard Capital Management
Pennsylvania
$79.7K +$87.3K +68,109 New
VFT
5
Vanguard Fiduciary Trust
Pennsylvania
$60.3K +$66.1K +51,578 New
Renaissance Technologies
6
Renaissance Technologies
New York
$57K +$15K +11,700 +32%
Prudential Financial
7
Prudential Financial
New Jersey
$32.8K +$35.9K +28,000 New
Northern Trust
8
Northern Trust
Illinois
$24K – – –
TSS
9
Two Sigma Securities
New York
$21.1K +$23.1K +18,056 New
VF
10
Virtu Financial
New York
$16K +$17.6K +13,751 New
EGM
11
Engineers Gate Manager
New York
$13.9K +$2.11K +1,643 +16%
BlackRock
12
BlackRock
New York
$11.6K – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$7.95K +$1.37K +1,071 +19%
Group One Trading
14
Group One Trading
Illinois
$1.12K -$455 -355 -27%
Morgan Stanley
15
Morgan Stanley
New York
$1.08K -$1.66K -1,297 -58%
SS
16
SBI Securities
Japan
$274 +$13 +10 +4%
VGA
17
Vanguard Global Advisers
Pennsylvania
$202 +$222 +173 New
Wells Fargo
18
Wells Fargo
California
$132 +$106 +83 +277%
UBS Group
19
UBS Group
Switzerland
$19 -$11.6K -9,043 -100%
BNP Paribas Financial Markets
20
BNP Paribas Financial Markets
France
$15 – – –
JP Morgan Chase
21
JP Morgan Chase
New York
$12 – – –
AF
22
Allworth Financial
California
$8 – – –
Fidelity Investments
23
Fidelity Investments
Massachusetts
$7 +$8 +6 New
TWC
24
TD Waterhouse Canada
Ontario, Canada
$6 +$1 +1 +25%
AWM
25
Activest Wealth Management
Florida
$4 – – –
1
2

BNGO Hedge Fund Activity: Q1 2026 in Review

32 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2026, worth a combined $1.02M — down 25% from $1.35M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BNGO positions and 8 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $129K. The largest seller was DRW Securities, exiting entirely with an estimated $258K sold.

  • 32 institutional investors held Bionano Genomics (BNGO) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $1.02M of Bionano Genomics stock for Q1 2026, down 25% quarter-over-quarter.
  • 9 funds opened new Bionano Genomics positions in Q1 2026 and 8 closed out, a net change of +1 holder.
  • The largest Bionano Genomics buyer in Q1 2026 was Geode Capital Management, an estimated $129K added.
  • The largest Bionano Genomics seller in Q1 2026 was DRW Securities, an estimated $258K sold.

Based on aggregated 13F filings for Q1 2026.